Clinical Trial Update: The SPECTRA Study [Phase 2]

View source ↗

Summary

Update on Amgen's SPECTRA study, a Phase 2 trial for rheumatoid arthritis, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED